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standard in bone grafting21). This method is preferred due to 
successful fusion rate and low risk of disease transmission11). 
However, this procedure is sometimes associated with unex-
pected morbidities such as fractures, hernia, ureteral injury, 
pelvic instability, infection, and chronic donor site pain21). In 
addition, there are several limitations aside from its morbidity 
including separate incision for harvesting, increased surgical 
time, and limited or insufficient amount of graft.
Demineralized bone matrix (DBM), which is produced from 
human allograft tissue, is an alternative to an autograft. DBM 
consists of bone morphogenic proteins (BMP), collagen, and 
other synergistic proteins such as transforming growth factor 
and insulin-like growth factor21). Therefore, DBM has osteoin-
INTRODUCTION
Spinal fusion is the most frequently performed surgery to 
treat spinal disorders. The ultimate aim of spinal fusion surgery 
is to achieve complete fusion at the index level. Non-union is a 
critical complication of this surgery, with a prevalence of ap-
proximately 10% to 40%21).
Equipment such as pedicle screws, rods, wires, and cages 
have been used to achieve fusion of unstable spinal segments. 
However, previous studies have reported that 10% to 15% of all 
such cases showed pseudoarthrosis21). Bone grafting is another 
strategy to augment spinal fusion. Autologous iliac bone graft is 
the most commonly used bone graft and is regarded as the gold 
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our institute. Of those patients, 65 received complete CT scans for 12 months postoperatively in order to evaluate fusion status. For comparison 
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sity (BMD). To evaluate the clinical outcomes, we analyzed the results of visual analogue scale (VAS), Oswestry Disability Index (ODI), and Short Form 
Health Survey (SF-36).
Results : We reviewed the CT scans of 149 fusion levels in 130 patients (HA-DBM group, 75 levels/65 patients; Autograft group, 74 levels/65 pa-
tients). Age, sex, BMI, and BMD were not significantly different between the groups (p=0.528, p=0.848, p=0.527, and p=0.610, respectively). The 
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tically significant (p=0.21). In the HA-DBM group, older age and low BMD were significantly associated with non-fusion (61.24 vs. 66.68, p=0.027; 
-1.63 vs. -2.29, p=0.015, respectively). VAS and ODI showed significant improvement after surgery when fusion was successfully achieved in both 
groups (p=0.004, p=0.002, HA-DBM group; p=0.012, p=0.03, Autograft group). 
Conclusion : The fusion rates of the hydroxyapatite DBM and Autograft groups were not significantly different. In addition, clinical outcomes were 
similar between the groups. However, older age and low BMD are risk factors that might induce non-union after surgery with hydroxyapatite DBM. 
Key Words : Hydroxyapatite · Autograft · Fusion · CT scan.
Clinical Article
• Received : November 9, 2015  • Revised : January 31, 2016  • Accepted : February 26, 2016
• Address for reprints : Yoon Ha, M.D., Ph.D.
 Department of Neurosurgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
 Tel : +82-2-2228-2150,  Fax : +82-2-393-9979,  E-mail : hayoon@yuhs.ac
• This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   
 which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
J Korean Neurosurg Soc 59 (4) : 363-367, 2016
http://dx.doi.org/10.3340/jkns.2016.59.4.363
Copyright © 2016 The Korean Neurosurgical Society 
Print ISSN 2005-3711  On-line ISSN 1598-7876www.jkns.or.kr
364
J Korean Neurosurg Soc 59 | July 2016
mined by the size of the cage. Each surgical technique requires 
an appropriate cage in terms of height, length, angle, and shape. 
Therefore, we used the optimal volume of DBM allograft in 
each case. When using autologous bone graft, the extracted 
lamina and spinous process were cut into small pieces and used 
to fill the cage.
Assessment of fusion state 
Fusion grade was assessed using coronal or sagittal recon-
struction images of lumbar CT scans. All CT scans were per-
formed at one year after surgery. The fusion grade was classified 
from Grade I to IV24). We classified Grade I (cortical union of 
the graft material and central trabecular continuity) and Grade 
II (cortical union of the structural graft material with partial 
trabecular incorporation) as “Fused” and Grade III (superior or 
inferior cortical non-union of the central graft material with 
partial trabecular discontinuity centrally) and Grade IV (both 
superior and inferior cortical non-union with a complete lack 
of central trabecular continuity) as “Not-fused” (Fig. 1).
We also measured clinical outcomes including visual ana-
logue scale (VAS) score, Oswestry Disability Index (ODI), and 
Short Form Health Survey (SF-36) score in order to compare 
the surgical outcomes between the two groups. 
Measurement validation 
To assess the reliability of the measurements, two examiners 
measured the fusion status twice at a one-week interval for each 
of the 130 cases. In cases of discrepancies, the fusion grade was 
determined through debate in conferences. Inter-examiner and 
intra-examiner ICC and 95% confidence interval (95% CI) 
were assessed. Inter-examiner reliability was assessed using the 
intra-class correlation coefficient (ICC) of data obtained for the 
measurement of fusion status between both examiners. Intra-
examiner reliability was assessed between the first and second 
measurements for each individual examiner.
Statistical analysis
The measured variables were analyzed using independent t-
test analysis and chi-square analysis. We applied the paired t-
ductive and osteoconductive characteristics that allow it to be 
used as a graft extender or substitute21). Hydroxyapatite is also 
frequently used as a graft extender or substitute because it has 
osteoinductive characteristics and augmentation of the osteo-
conductive features of an autograft25). According to prior inves-
tigations, hydroxyapatite shows nearly equivalent fusion results 
to autografts1,23,25). 
Many trials have been conducted on the surgical outcomes of 
spinal fusion surgery using allografts. Reportedly, in many tri-
als, the fusion rates of DBM were similar to those of autografts. 
Cammisa et al.8) reported a 52% fusion rate in Grafton DBM in 
lumbar spinal surgery, which is comparable to 54% when using 
autografts. An et al.2) reported a 54% fusion rate in anterior cer-
vical fusion surgery using Grafton DBM and 74% when using 
autografts. However, many of these studies evaluated the fusion 
status using plain radiographs.
Hydroxyapatite DBM is a newly designed material, the fusion 
rate of which has not yet been reported. In this study, we inves-
tigated and compared the fusion rates of hydroxyapatite DBM 
and autografts using CT scans at 12 months after operation. In 
addition, we measured clinical scores to evaluate the impact of 
fusion on clinical outcomes.
MATERIALS AND METHODS
Patient population
From January 2013 to April 2014, 98 patients diagnosed with 
lumbar stenosis underwent lumbar interbody fusion surgery 
using hydroxyapatite DBM (BonfuseTM, CG Bio, Seoul, Korea) 
in Severance Hospital. This study was approved by the institu-
tional review boards at Severance Hospital. We excluded pa-
tients with a history of infection, trauma, spinal tumor, spondy-
lolytic spondylolisthesis, or previous spinal surgery. Patients 
using steroid medications or who had metabolic bone disease 
such as Paget’s disease or renal osteodystrophy were also ex-
cluded. Ultimately, 65 patients (75 interbody levels) were eligi-
ble for this study and underwent postoperative CT scans for 12 
months (the HA-DBM group). Another 65 patients (74 inter-
body levels) who underwent lumbar interbody fusion surgery 
using autograft during the same period were enrolled for com-
parison (the Autograft group). The subjects in the Autograft 
group were of similar age, sex, bone mineral density (BMD), 
and body mass index (BMI) and also underwent postoperative 
CT scans for 12 months. Therefore, a total of 130 patients (149 
interbody levels) were evaluated using CT scans.
Operative technique
One fusion technique [posterior lumbar interbody fusion, 
(PLIF) anterior lumbar interbody fusion (ALIF) or transforami-
nal lumbar interbody fusion (TLIF)] was performed in each pa-
tient. We performed pedicle screw fixation on each PLIF and 
TLIF case. All of TLIF cases were open TLIF and minimal inva-
sive TLIF was not conducted. The DBM volume was deter-
A B
Fig. 1. Fusion assessment using computed tomography (CT) scan. A : 
Fused, cortical continuity was observed without a visual gap on CT scan, 
white arrow. B : Not fused, cortical discontinuity was observed with a vi-
sual gap, black arrow.
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test to compare the clinical outcomes in each group. Analysis 
was conducted using the PASW statistics 18 software program 
(PASW, IBM, USA). A p<0.05 was considered statistically sig-
nificant.
RESULTS
Mean age was not significantly different between the groups 
(HA-DBM group 63.66±10.19 vs. Autograft group 62.54±10.04, 
p=0.528). In addition, sex ratio (HA-DBM group 16 : 46 vs. Au-
tograft group 20 : 45, p=0.848), BMD (HA-DBM group -1.91± 
1.06 vs. Autograft group -2.05±1.27, p=0.527), and BMI (HA-
DBM group 27.39±3.03 vs. Autograft group 25.55±3.75, 
p=0.610) were not significantly different. The HA-DBM group 
contained three cases of ALIF and the Autograft group none 
(Table 1). 
In the HA-DBM group, 39 interbody levels were “Fused” and 
36 interbody levels were “Not-fused,” resulting in a 52% fusion 
rate. In the Autograft group, 49 interbody levels were “Fused” 
and 28 levels were “Not-fused,” resulting in a 62.2% fusion rate. 
Fusion rate was not statistically significantly different between 
the two groups (p=0.21) (Table 2).
Next, we compared the “Fused” subgroup with the “Not-
fused” subgroup in each group. In the HA-DBM group, the 
“Fused” subgroup showed significantly lower mean age than 
the “Not-fused” subgroup (“Fused” subgroup 61.24±9.45 vs. 
“Not-fused” subgroup 66.86±10.42, p=0.027). In addition, the 
BMD was significantly lower in the “Not-fused” subgroup 
(“Fused” subgroup -1.63±0.90 vs. “Not-fused” subgroup -2.29± 
1.16, p=0.015). Conversely, there were no significant differences 
between the “Fused” and the “Not-fused” subgroups in the Au-
tograft group (Table 3). 
VAS and ODI were improved significantly in the HA-DBM 
group regardless of fusion (preoperative 5.3, postoperative 2.9; 
preoperative 40.8, postoperative 48.6 in “Fused”; preoperative 
6.2, postoperative 3.4; preoperative 48.6, postoperative 29.7 in 
“Not-fused”). In the Autograft group, VAS and ODI showed 
significant improvement in the “Fused” subgroup (preoperative 
5.0, postoperative 2.6 and preoperative 41.2, postoperative 28.6, 
respectively) but not in the “Not-fused” subgroup (p=0.192). The 
Table 1. Group demographics 
HA-DBM group,
mean±SD
Autograft group,
mean±SD p-value
Age (years) 63.66±10.19 62.54±10.04 0.528
Sex (M : F) 16 : 46 20 : 45 0.848*
BMD (T-score) -1.91±1.06 -2.05±1.27 0.527
BMI (kg/m2) 27.39±3.03 25.55±3.75 0.610
Procedure 
PLIF 36 47
ALIF 3 0
TLIF 36 27
Independent t-test was performed. *Chi-square tests were performed. HA-DBM : 
hydroxyapatite-demineralized bone matrix allograft, BMD : bone mineral density, 
BMI : body mass index, PLIF : posterior lumbar interbody fusion, ALIF : anterior 
lumbar interbody fusion, TLIF : transforaminal lumbar interbody fusion, SD : stan-
dard deviation
Table 2. Comparison of fusion rates at postoperative 12 months
HA-DBM group Autograft group p-value
Fused levels 39 46
Not fused levels 36 28
Fusion rate (%) 52 62.2 0.210*
*Chi-square tests were performed to analyze the fusion rate. Fusion rate=fused 
levels/(fused+not fused levels) ×100. HA-DBM : hydroxyapatite demineralized 
bone matrix
Table 3. Comparison of demographics in terms of fusion 
HA-DBM group Autograft group
Fused, mean±SD Not fused, mean±SD p-value Fused, mean±SD Not fused, mean±SD p-value
Age (years) 61.24±9.45 66.86±10.42 0.027 61.71±11.06 63.7±8.46 0.435
Sex (M : F) 9 : 28 10 : 18 0.317* 14 : 24 6 : 21 0.208*
BMD (T-score) -1.63±0.90 -2.29±1.16 0.015 -2.08±1.39 -2.01±1.12 0.855
BMI (kg/m2) 23.72±3.22 24.04±2.80 0.675 25.59±3.83 25.48±3.70 0.908
Independent t-test was performed. *Chi-square tests were performed. HA-DBM : hydroxyapatite demineralized bone matrix, BMD : body mass index, BMI : bone miner-
al density
Table 4. Comparison of clinical outcomes between groups
HA-DBM group Autograft group
Fused Not fused Fused Not fused
Preoperative, 
mean±SD
Postoperative, 
mean±SD p-value 
Preoperative, 
mean±SD
Postoperative, 
mean±SD p-value 
Preoperative, 
mean±SD
Postoperative, 
mean±SD p-value
Preoperative, 
mean±SD
Postoperative, 
mean±SD p-value 
VAS 5.31±2.52 2.93±2.17 0.004 6.16±2.36 3.45±2.56 0.008 5.01±3.21 2.56±2.17 0.012 3.56±3.62 2.21±1.59 0.192
ODI 40.8±15.5 22.3±19.3 0.002 48.6±21.7 29.7±16.3 0.005 41.2±14.3 28.6±20.3 0.030 36.0±14.4 25.8±15.5 0.149
PCS 55.7±11.8 51.9±6.3 0.455 51.6±2.8 53.4±1.4 0.626 53.8±6.5 56.7±19.9 0.528 54.5±6.2 45.9±6.9 0.885
MCS 51.4±18.4 54.9±14.4 0.302 58.3±21.2 60.5±17.6 0.500 48.0±9.2 57.9±16.6 0.456 49.6±7.4 58.9±13.0 0.076
Paired t-test was performed to analyze the clinical outcome score. VAS : visual analogue scale, ODI : Oswestry Disability Index, PCS : physical component score, MCS : 
mental component score
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SF-36 score, which was composed of a physical component score 
(PCS) and a mental component score (MCS), was not signifi-
cantly different between the groups regardless of fusion (Table 4).
DISCUSSION
Spinal fusion surgery is the treatment of choice in various 
spinal disorders. Pseudoarthrosis has remained a challenging 
problem with this surgery; thus, bone grafts are used to alleviate 
this problem. Due to the limitations of iliac bone graft, local 
corticocancellous bone chip acquired from laminectomy is fre-
quently used. The fusion results whether using local bone chip 
or iliac bone graft are equivalent15). However, limited volume 
might results from this conventional method and can be unfa-
vorable in some cases with a low proportion of cancellous bone 
in the local graft4). As an alternative, DBM products were devel-
oped to use as a graft expander or substitute. The fusion rates of 
previous commercial DBM products are similar to those of Au-
tograft8,13,16).
The fusion achieved when using DBM and hydroxyapatite 
mixtures have been evaluated in several trials. According to Lee 
et al.20), the combined use of DBM and hydroxyapatite indicated 
osteoblastic differentiation in vitro. They showed that the mix-
ture has osteoinductive characteristics by performing  in vitro 
studies. In addition, many clinical trials have reported success-
ful fusion results with hydroxyapatite DBM25,26). Osteoinductiv-
ity and osteoconductivity were present in the hybrid compound, 
indicating that hydroxyapatite with DBM can be an adjunct to 
autografts25).
Our results showed a lower fusion rate in the hydroxyapatite 
HA-DBM group than the Autograft group, although the differ-
ence was not statistically significant. Many previous studies 
have reported lower fusion rates of DBM allograft than auto-
graft, but also without statistical significance8,10,16). Although the 
fusion rates of DBM allograft were lower than those of auto-
graft, the surgical outcomes of DBM allograft were not inferior 
to those of autograft8,10,16), suggesting that DBM allograft is a 
good alternative to autograft21). The overall fusion rates in previ-
ous studies were higher than those in the present study8,16). Fu-
sion rates in previous articles regarding allograft material vary 
widely from 60% to 98%7). We believe these differences origi-
nated from the different methods used for fusion assessment. 
Most previous studies assessed fusion status using plain radio-
graphs; however, CT scans are more reliable to evaluate the ex-
act fusion status9,19). Therefore, the fusion rate assessed using 
CT scans is more accurate and more precisely represents the fu-
sion rate. 
Unlike the Autograft group, the fusion rate in the HA-DBM 
group was affected by age and BMD. Okuyama et al.22) reported 
that pseudoarthrosis was more frequent in patients with low 
BMD. In addition, Inoue et al.14) reported that bone formation 
is decreased in older patients due to a smaller number of stro-
mal cells in bone marrow. In addition, in animal studies, bone 
healing was shown to require a longer time in older age5). Low 
BMD and older age are risk factors for non-union. However, 
these factors affected only the HA-DBM group in our study. 
This finding suggests that hydroxyapatite DBM is more suscep-
tible to age and BMD than is autograft. Consequently, when 
considering spinal fusion surgery with DBM products, older 
age and low BMD should be taken into account as risk factors. 
We measured clinical scores by evaluating VAS, ODI, and SF-
36 (PCS and MCS) scores. The VAS and ODI score after sur-
gery were improved in both groups. These results are similar to 
other previous studies10,16). The improvements were statistically 
significant except in the “Not-fused” subgroup of the Autograft 
group. This result might be due to the small number of enrolled 
patients. In addition, the changes in SF-36 score were not sig-
nificant after surgery. We also believe that 12 months is a rela-
tively short period in which to achieve complete fusion status, 
and bone formation and tissue healing might be ongoing at fu-
sion sites.
This study had several limitations. First, CT scans were per-
formed 12 months after surgery. Considering that a two-year 
follow-up has been proposed as the time required to definitively 
evaluate the solidity and stability of spine fusion6), 12 months 
might be too short to precisely evaluate fusion status and can 
lead to underestimation of fusion results. The other limitation 
was that we did not consider other factors that might affect fu-
sion status. Diabetes mellitus is known to reduce the fusion rate 
in spinal surgery12). Diabetes delays the postoperative bone heal-
ing process stimulated by enhanced tumor necrosis factor α  to 
reduce proliferation and promote necrosis of mesenchymal stem 
cells17). Additionally, local insulin concentration can affect the 
fusion results by modifying the level of insulin like growth fac-
tor-1 at the fusion site18). Smoking also affects bone formation. 
An et al.2) and Anderson et al.3) reported that nicotine disturbs 
the microcirculation of fusion beds and affects the fusion rate.
CONCLUSION
This study demonstrated that the fusion rates of a hydroxy-
apatite HA-DBM group and Autograft group were not signifi-
cantly different. In addition, the clinical outcomes were similar 
between the groups. Therefore, the hydroxyapatite DBM al-
lograft can be used as an alternative to conventional autologous 
bone grafts but should be carefully considered in older or low-
BMD patients.
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